Study shows effectiveness of Arthrosurface shoulder device
Photo | Google
Arthrosurface's Franklin offices
A medical device by Franklin firm Arthrosurface has been shown in a new study to provide clinical benefits for those with arthritis, a new study says.
Arthrosurface's OVO with Inlay Glenoid Shoulder Arthroplasty System, an implant that hit the market a year ago, is meant to help patients with glenohumeral arthritis, a degenerative shoulder condition.
A study published in this month in the Journal of Shoulder and Elbow Surgery by doctors at the Cleveland Clinic said the device demonstrated excellent clinical benefits for patients. The study called the device a promising option for patients with glenohumeral arthritis, even those with a condition known as posterior glenoid erosion, referring to a wearing away of part of the shoulder bone. It was said to allow for a wide range of shoulder motion.
The study covered 31 shoulders in 29 patients, with an average age of 58.5 years old.
The Arthrosurface device was cleared by the U.S. Food and Drug Administration in April 2018 and launched last October.
WBJ Web Partners
Most Recent
Most Recent
0 Comments